<div id="readability-page-1" class="page">11:10 AM EDT, 03/10/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts late Tuesday morning, rising 1.12% to 1,777.07 on the S&amp;P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion ( EVAX ) and biopharmaceutical company Cellectis ( CLLS ) , which climbed 8.4% and 5.6% respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and lender Banco Santander (SAN), which advanced 3.7% and 3.1% respectively.The decliners from continental Europe were led by biotech firm BioNTech (BNTX) and furniture maker Natuzzi (NTZ), which tumbled 21% and 18% respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and pharmaceutical company Novo Nordisk ( NVO ) , which lost 4.1% and 3.2% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and NuCana ( NCNA ) , which rose 6.6% and 5.1% respectively. They were followed by biopharmaceutical company Amarin ( AMRN ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were up 3.6% and 2.8% respectively.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and software company Endava ( DAVA ) , which dropped 8.1% and 4% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and communications company WPP ( WPP ) , which lost 2.6% and 1.6% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

AKTX

BNTX

EVAX

TRIB

DAVA

CLLS

NCNA

SPEU

European equities traded in the US as American depositary receipts rose 1.12% to 1,777.07 on the S&P Europe Select ADR Index. Notable gainers included Evaxion (8.4%) and Cellectis (5.6%), while decliners included BioNTech (-21%) and Natuzzi (-18%). From the UK and Ireland, Akari Therapeutics (6.6%) and NuCana (5.1%) led the gains, whereas Trinity Biotech (-8.1%) and Endava (-4%) were the biggest decliners.

Fidelity

Akari Therap

BioNTech SE

Evaxion A/S

Trinity Biotech

Endava

Cellectis

Nucana

SPDR Portfolio Europe ETF

First Trust STOXX EUROPE

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading